Lantus and Chronulac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Chronulac (lactulose). Common drug interactions include back pain among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and Chronulac. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Chronulac?

Chronulac has active ingredients of lactulose. eHealthMe is studying from 360 Chronulac users. Check the latest studies of Chronulac.

On Jul, 15, 2026

20 people who take Lantus and Chronulac together, and have interactions are studied.

What are the common drug interactions of Lantus and Chronulac, by gender? *:

female:

Back pain
Cellulitis (infection under the skin)
Renal failure (kidney dysfunction)
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Cardiac failure congestive
Dehydration (dryness resulting from the removal of water)

male:

Fall
Ascites (accumulation of fluid in the abdominal cavity)
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood glucose decreased
Cardiac failure congestive
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Depression
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Disease complication

What are the common drug interactions of Lantus and Chronulac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Cardiac failure congestive
Depression
Emotional distress
Fatigue (feeling of tiredness)
Lethargy (tiredness)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Negative thoughts

50-59:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Back pain
Cellulitis (infection under the skin)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic lesion
Memory impairment

60+:

Fall
Influenza
Back pain
Bacterial infection
Cardiac failure congestive
Cellulitis (infection under the skin)
Chronic kidney disease
Disease complication
Dyspnoea (difficult or laboured respiration)
Electrocardiogram t wave inversion

What are the existing conditions these people have? *

Pain: 9 people, 45.00%
Constipation: 6 people, 30.00%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 6 people, 30.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 25.00%
High Blood Pressure: 4 people, 20.00%
Depression: 4 people, 20.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 15.00%
High Blood Cholesterol: 3 people, 15.00%
Hypersensitivity: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and Chronulac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously